Skip to content

Computerized Cognitive Exercise Training Treatment for Adults With Multiple Sclerosis

Plasticity-based, Adaptive, Computerized Cognitive Remediation Treatment (PACR) for Adults With Multiple Sclerosis (MS)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02141386
Enrollment
136
Registered
2014-05-19
Start date
2013-09-30
Completion date
Unknown
Last updated
2015-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Multiple Sclerosis, Cognitive remediation, Plasticity-based, adaptive, computerized cognitive remediation, Cognitive impairment

Brief summary

Cognitive impairment remains a major disability for individuals with multiple sclerosis (MS). The primary objective of this study is to evaluate the efficacy for treating MS-associated cognitive deficits using a unique computer-based plasticity-based and adaptive cognitive remediation treatment (PACR) compared to a computer-based control. This novel cognitive remediation approach has led to striking improvements in cognitive functioning in other disorders (schizophrenia, traumatic brain injury, aging, and dementia) but has never been applied to individuals with MS. The investigators will enroll 136 MS participants who will be randomized in a 2:1 pattern to complete either the treatment or control condition for 60 hours across a 12-week treatment period. Both the treatment and control conditions will be accessed remotely by the subjects from a study-provided laptop computer. Study outcomes will include program compliance, performance on study tasks and neuropsychological measures, quality of life and functional status. Given the success of this program with other disorders and strong preliminary data from our feasibility study, the investigators believe PACR is an exciting untapped opportunity to improve cognition in individuals with MS.

Interventions

OTHERPACR (Plasticity-based, Adaptive, Computerized Cognitive Remediation)

Sponsors

National Multiple Sclerosis Society
CollaboratorOTHER
Stony Brook University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Ages 18-70 * Definite MS Diagnosis, any subtype \[83\] * Probable cognitive impairment as defined by a score ≤ 1 SD below the mean of normative data on the SDMT * Concurrent medications to be kept constant over three months (as possible) * No relapse or steroids in previous month * Reading score on WRAT-3 of 37 or greater * Visual, auditory and motor capacity to operate computer software, as judged by treating neurologist or study staff * Willing to sign Agreement to Borrow Laptop

Exclusion criteria

* History of mental retardation, pervasive developmental disorder or other neurological condition associated with cognitive impairment * Primary psychiatric disorder that would influence ability to participate * Other serious uncontrolled medical condition (e.g., cancer or acute myocardial infarction) * Alcohol or other substance use disorder * History of computer-based training manufactured by Posit Science * Learned English language after 12 years of age

Design outcomes

Primary

MeasureTime frameDescription
A composite derived from a standardized battery of neuropsychological tests12weeksCovariates will include baseline cognitive status, PACR program compliance, PACR task improvement, and participant-reported outcomes

Secondary

MeasureTime frame
A timed measure based on direct observation of functional performance12 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026